A simple, sensitive, and low-cost FACS assay for detecting antibodies against the native SARS-CoV-2 spike protein
Standard
A simple, sensitive, and low-cost FACS assay for detecting antibodies against the native SARS-CoV-2 spike protein. / Hambach, Julia; Stähler, Tobias; Eden, Thomas; Wendt, Dorte; Tode, Natalie; Haag, Friedrich; Tolosa, Eva; Altfeld, Marcus; Fathi, Anahita; Dahlke, Christine; Addo, Marylyn M; Menzel, Stephan; Koch-Nolte, Friedrich.
In: IMMUN INFLAMM DIS, Vol. 9, No. 3, 09.2021, p. 905-917.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - A simple, sensitive, and low-cost FACS assay for detecting antibodies against the native SARS-CoV-2 spike protein
AU - Hambach, Julia
AU - Stähler, Tobias
AU - Eden, Thomas
AU - Wendt, Dorte
AU - Tode, Natalie
AU - Haag, Friedrich
AU - Tolosa, Eva
AU - Altfeld, Marcus
AU - Fathi, Anahita
AU - Dahlke, Christine
AU - Addo, Marylyn M
AU - Menzel, Stephan
AU - Koch-Nolte, Friedrich
N1 - © 2021 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
PY - 2021/9
Y1 - 2021/9
N2 - BACKGROUND: Hamburg is a city state of approximately 1.9 Mio inhabitants in Northern Germany. Currently, the COVID-19 epidemic that had largely subsided during last summer is resurging in Hamburg and in other parts of the world, underlining the need for additional tools to monitor SARS-CoV-2 antibody responses.AIM: We aimed to develop and validate a simple, low-cost assay for detecting antibodies against the native coronavirus 2 spike protein (CoV-2 S) that does not require recombinant protein or virus.METHOD: We transiently co-transfected HEK cells or CHO cells with expression vectors encoding CoV-2 S and nuclear GFP. Spike protein-specific antibodies in human serum samples bound to transfected cells were detected with fluorochrome conjugated secondary antibodies by flow cytometry orimmunofluorescence microscopy. We applied this assay to monitor antibody development in COVID-19 patients, household contacts, and hospital personnel during the ongoing epidemic in the city state of Hamburg.RESULTS: All recovered COVID-19 patients showed high levels of CoV-2 S-specific antibodies. With one exception, all household members that did not develop symptoms also did not develop detectable antibodies. Similarly, lab personnel that worked during the epidemic and followed social distancing guidelines remained antibody-negative.CONCLUSION: We conclude that high-titer CoV-2 S-specific antibodies are found in most recovered COVID-19 patients and in symptomatic contacts, but only rarely in asymptomatic contacts. The assay may help health care providers to monitor disease progression and antibody responses in vaccination trials, to identify health care personnel that likely are resistant to re-infection, and recovered individuals with high antibody titers that may be suitable asplasma and/or antibody donors.
AB - BACKGROUND: Hamburg is a city state of approximately 1.9 Mio inhabitants in Northern Germany. Currently, the COVID-19 epidemic that had largely subsided during last summer is resurging in Hamburg and in other parts of the world, underlining the need for additional tools to monitor SARS-CoV-2 antibody responses.AIM: We aimed to develop and validate a simple, low-cost assay for detecting antibodies against the native coronavirus 2 spike protein (CoV-2 S) that does not require recombinant protein or virus.METHOD: We transiently co-transfected HEK cells or CHO cells with expression vectors encoding CoV-2 S and nuclear GFP. Spike protein-specific antibodies in human serum samples bound to transfected cells were detected with fluorochrome conjugated secondary antibodies by flow cytometry orimmunofluorescence microscopy. We applied this assay to monitor antibody development in COVID-19 patients, household contacts, and hospital personnel during the ongoing epidemic in the city state of Hamburg.RESULTS: All recovered COVID-19 patients showed high levels of CoV-2 S-specific antibodies. With one exception, all household members that did not develop symptoms also did not develop detectable antibodies. Similarly, lab personnel that worked during the epidemic and followed social distancing guidelines remained antibody-negative.CONCLUSION: We conclude that high-titer CoV-2 S-specific antibodies are found in most recovered COVID-19 patients and in symptomatic contacts, but only rarely in asymptomatic contacts. The assay may help health care providers to monitor disease progression and antibody responses in vaccination trials, to identify health care personnel that likely are resistant to re-infection, and recovered individuals with high antibody titers that may be suitable asplasma and/or antibody donors.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Animals
KW - Antibodies, Viral/analysis
KW - COVID-19/immunology
KW - Cricetinae
KW - Cricetulus
KW - Flow Cytometry
KW - HEK293 Cells
KW - Humans
KW - Middle Aged
KW - SARS-CoV-2/immunology
KW - Spike Glycoprotein, Coronavirus/immunology
U2 - 10.1002/iid3.446
DO - 10.1002/iid3.446
M3 - SCORING: Journal article
C2 - 33979020
VL - 9
SP - 905
EP - 917
JO - IMMUN INFLAMM DIS
JF - IMMUN INFLAMM DIS
SN - 2050-4527
IS - 3
ER -